☰

Bang-Chool Kim, Ph.D. - Publications

Affiliations: 
2001 Ohio State University, Columbus, Columbus, OH 
Area:
Physical Education
Tree Info Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Kim SY, Kim SM, Chang H, Kim BW, Lee YS, Chang HS, Park CS. Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea. Frontiers in Endocrinology. 10: 384. PMID 31244783 DOI: 10.3389/fendo.2019.00384  0.307
2018 Lee YS, Kim SM, Kim BW, Chang HJ, Kim SY, Park CS, Park KC, Chang HS. Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells. Neoplasia (New York, N.Y.). 20: 197-206. PMID 29331886 DOI: 10.1016/j.neo.2017.12.003  0.315
2017 Park KC, Kim SM, Jeon JY, Kim BW, Kim HK, Chang HJ, Lee YS, Kim SY, Choi SH, Park CS, Chang HS. Synergistic activity of N-hydroxy-7-(2-naphthylthio) heptanomide and sorafenib against cancer stem cells, anaplastic thyroid cancer. Neoplasia (New York, N.Y.). 19: 145-153. PMID 28142087 DOI: 10.1016/j.neo.2016.12.005  0.315
2012 Garg K, Rockman CB, Kim BJ, Jacobowitz GR, Maldonado TS, Adelman MA, Veith FJ, Cayne NS. Outcome of endovascular repair of popliteal artery aneurysm using the Viabahn endoprosthesis. Journal of Vascular Surgery. 55: 1647-53. PMID 22608040 DOI: 10.1016/j.jvs.2011.12.059  0.488
Show low-probability matches.